Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells

Marina Pisano1, Gabriella Pagnan, Monica Loi

  • 1Bio-molecular Chemistry Institute, National Research Council, Sassari, Italy. marina.pisano@icb.cnr.it

Molecular Cancer
|January 20, 2007
PubMed
Abstract

Insights

Researchers identified a novel compound, (S)-6,6'-dibromo-dehydrodieugenol, that selectively inhibits melanoma cell growth by inducing apoptosis. This eugenol-related biphenyl shows promise as a potential new therapy for aggressive skin cancer.

Area of Science:

  • Oncology
  • Dermatology
  • Medicinal Chemistry

Background:

  • Malignant melanoma is an aggressive skin cancer with limited treatment options.
  • Current chemotherapeutic agents for melanoma are unsatisfactory.
  • Novel therapeutic strategies are urgently needed to combat rising melanoma incidence and mortality.

Purpose of the Study:

  • To identify and evaluate novel compounds for antiproliferative and cytotoxic activity against melanoma cells.
  • To investigate the potential of eugenol and related compounds as anti-melanoma agents.

Main Methods:

  • Primary melanoma cell lines were established from patient tissue samples.
  • Eugenol and six related compounds were tested for their ability to inhibit cell growth.
  • Antiproliferative and cytotoxic effects were assessed using dose-response and time-dependence studies.
  • Apoptosis was evaluated using TUNEL and phosphatidylserine exposure assays.
  • Caspase activation was investigated in relation to observed cytotoxicity.

Main Results:

  • Eugenol and its simple derivatives showed no significant antiproliferative effects.
  • Dimeric eugenol derivatives (biphenyls) exhibited antiproliferative activity.
  • The brominated biphenyl (S)-6,6 -dibromo-dehydrodieugenol (S7-(S)) demonstrated marked antiproliferative and cytotoxic activity.
  • This activity was selective for melanoma cells, sparing normal human skin fibroblasts.
  • S7-(S) induced apoptosis in melanoma cells, partially through caspase activation.

Conclusions:

  • The eugenol-related biphenyl (S)-6,6 -dibromo-dehydrodieugenol exhibits specific antiproliferative effects on neuroectodermal tumor cells.
  • This compound partially triggers apoptosis, suggesting a potential mechanism of action.
  • Further in vivo investigation is warranted to assess the anticancer effectiveness of (S)-6,6 -dibromo-dehydrodieugenol in melanoma models.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...